Get started
Author

Kristin Decker

Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs
2020 · Maren Pein, Jacob Insua-Rodríguez, et al. · Nature Communications · 198
PDF
Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs
2022 · Tsunaki Hongu, Maren Pein, et al. · Nature Cancer · 123
Abstract 1523: Subcutaneous dosing of amatoxin-based ADCs increases the therapeutic index
2023 · Kristin Decker, Marija Vranic, et al. · Cancer Research · 8
Abstract 1754: Amatoxin-based antibody-drug conjugates induce immunogenic cell death and improve the anti-tumor efficacy of immune checkpoint inhibitors in humanized mouse models
2022 · Christian Orlik, Franziska Ebeling, et al. · Cancer Research · 3
Abstract 7183: Liver toxicity of amanitin-based antibody drug conjugates (ATACs) is caused by unspecific uptake of the ATAC into liver cells
2024 · Christian Orlik, Kristin Decker, et al. · Cancer Research · 2
Abstract 2636: Amanitin-based ADCs targeting Guanylyl cyclase C (GCC) as novel therapeutic modality for treatment of colorectal cancer
2023 · Alexandra Braun, Andreas Pelz, et al. · Cancer Research · 2
Abstract 921: Combination of antibody-targeted amanitin conjugates (ATAC) with immune checkpoint inhibitors shows synergistic therapeutic effect in vitro and in vivo
2021 · Kristin Decker, Irina Dranova, et al. · Cancer Research · 2
Abstract 1558: HDP-201 - a novel multimeric linker exatecan-based ADC targeting Guanylyl cyclase C (GCC) for treatment of gastrointestinal malignancies
2025 · Sarah Jane Neuberth, Christian Orlik, et al. · Cancer Research · 1
Abstract 1865: HDP-102 - a CD37-targeting Amanitin-based-ADC for the treatment of NHL - non-clinical data package
2024 · Sarah-Jane Neuberth, Kristin Decker, et al. · Cancer Research · 1
Supplementary Figure S8 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Figure S2 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Figure S12 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Table S1 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Table S2 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Data from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Figure S13 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Figure S11 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Figure S1 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Figure S5 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Figure S6 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Figure S9 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Figure S3 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Figure S7 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Figure S10 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Supplementary Figure S4 from Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
2026 · Daniela Carraturo, Francesca Gallo, et al.
Works count: 32
Citation count: 340
H-index: 3
I10-index: 2
Year
Topic
Type